BioCatalyst

ARO-DM1 Intravenous (IV) Infusion, ARO-DM1 subcutaneous (SC) injection — catalyst calendar

1 verified catalyst event(s) referencing ARO-DM1 Intravenous (IV) Infusion, ARO-DM1 subcutaneous (SC) injection, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
Phase 1/2 · Myotonic Dystrophy 1
 ARWR ARROWHEAD PHARMACEUTICALS, I ARO-DM1 Intravenous (IV) Infusion, ARO-D ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.